FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296692034> ?p ?o ?g. }

• W4296692034 endingPage "113362" @default.
• W4296692034 startingPage "113362" @default.
• W4296692034 abstract "Triple-negative breast cancer (TNBC) accounts for about 15% of diagnosed breast cancer patients, which has a poor survival outcome owing to a lack of effective therapies. This study aimed to explore the in vitro and in vivo efficiency of histone deacetylase (HDAC) inhibitor panobinostat (PANO) in combination with mTOR inhibitor rapamycin (RAPA) against TNBC. TNBC cells were treated with PANO, RAPA alone or the combination of drugs, then cell growth and apoptosis were evaluated by CCK-8, colony formation and flow cytometry. Cell migration and invasion were detected by wound healing assay and transwell assay, respectively. ROS production was detected by DCFH-DA staining. Western blotting was performed to detect protein levels. In vivo tumor growth was assessed in nude mice. The expression of cleaved caspase-3 and Ki-67 in tumor tissues was detected by immunofluorescence staining. H&E staining was conducted to observe the pathological changes in heart, liver, and kidney tissues. The combination of PANO and RAPA exerted a stronger role in repressing growth, migration, invasion, and inducing apoptosis of TNBC cells compared with monotherapy. Furthermore, this combination presented a more effective anti-cancer efficacy than a single treatment in the xenograft model without apparent toxic side effects. Importantly, mechanistic studies indicated that PANO and RAPA combination led to ROS overproduction, which subsequently activated endoplasmic reticulum stress. Conclusion: PANO in combination with RAPA exhibits enhanced efficacy against TNBC, which may be considered a promising therapeutic candidate." @default.
• W4296692034 created "2022-09-23" @default.
• W4296692034 creator A5010474315 @default.
• W4296692034 creator A5021875517 @default.
• W4296692034 creator A5026338064 @default.
• W4296692034 creator A5040655463 @default.
• W4296692034 creator A5050733128 @default.
• W4296692034 creator A5054577292 @default.
• W4296692034 creator A5057762207 @default.
• W4296692034 creator A5058800141 @default.
• W4296692034 creator A5074036516 @default.
• W4296692034 date "2022-12-01" @default.
• W4296692034 modified "2023-09-23" @default.
• W4296692034 title "Histone deacetylase inhibitor panobinostat in combination with rapamycin confers enhanced efficacy against triple-negative breast cancer" @default.
• W4296692034 cites W1934530049 @default.
• W4296692034 cites W1968820334 @default.
• W4296692034 cites W1991327582 @default.
• W4296692034 cites W2018022997 @default.
• W4296692034 cites W2024224076 @default.
• W4296692034 cites W2050684389 @default.
• W4296692034 cites W2071361048 @default.
• W4296692034 cites W2078631320 @default.
• W4296692034 cites W2108144416 @default.
• W4296692034 cites W2109358988 @default.
• W4296692034 cites W2125380142 @default.
• W4296692034 cites W2126782531 @default.
• W4296692034 cites W2127967682 @default.
• W4296692034 cites W2128955440 @default.
• W4296692034 cites W2143643269 @default.
• W4296692034 cites W2162622637 @default.
• W4296692034 cites W2169634553 @default.
• W4296692034 cites W2496640702 @default.
• W4296692034 cites W2518718875 @default.
• W4296692034 cites W2565453971 @default.
• W4296692034 cites W2595349270 @default.
• W4296692034 cites W2728962997 @default.
• W4296692034 cites W2736680212 @default.
• W4296692034 cites W2766900039 @default.
• W4296692034 cites W2892889246 @default.
• W4296692034 cites W2905333233 @default.
• W4296692034 cites W2978126835 @default.
• W4296692034 cites W3006976636 @default.
• W4296692034 cites W3007210211 @default.
• W4296692034 cites W3016510951 @default.
• W4296692034 cites W3036977922 @default.
• W4296692034 cites W3097787693 @default.
• W4296692034 cites W3097808115 @default.
• W4296692034 cites W3119240638 @default.
• W4296692034 cites W3130665539 @default.
• W4296692034 cites W3134911824 @default.
• W4296692034 cites W3135188769 @default.
• W4296692034 doi "https://doi.org/10.1016/j.yexcr.2022.113362" @default.
• W4296692034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36152730" @default.
• W4296692034 hasPublicationYear "2022" @default.
• W4296692034 type Work @default.
• W4296692034 citedByCount "3" @default.
• W4296692034 countsByYear W42966920342023 @default.
• W4296692034 crossrefType "journal-article" @default.
• W4296692034 hasAuthorship W4296692034A5010474315 @default.
• W4296692034 hasAuthorship W4296692034A5021875517 @default.
• W4296692034 hasAuthorship W4296692034A5026338064 @default.
• W4296692034 hasAuthorship W4296692034A5040655463 @default.
• W4296692034 hasAuthorship W4296692034A5050733128 @default.
• W4296692034 hasAuthorship W4296692034A5054577292 @default.
• W4296692034 hasAuthorship W4296692034A5057762207 @default.
• W4296692034 hasAuthorship W4296692034A5058800141 @default.
• W4296692034 hasAuthorship W4296692034A5074036516 @default.
• W4296692034 hasConcept C104317684 @default.
• W4296692034 hasConcept C121608353 @default.
• W4296692034 hasConcept C190283241 @default.
• W4296692034 hasConcept C2776202225 @default.
• W4296692034 hasConcept C2778305200 @default.
• W4296692034 hasConcept C2780110267 @default.
• W4296692034 hasConcept C2780225316 @default.
• W4296692034 hasConcept C502942594 @default.
• W4296692034 hasConcept C530470458 @default.
• W4296692034 hasConcept C54355233 @default.
• W4296692034 hasConcept C55493867 @default.
• W4296692034 hasConcept C64927066 @default.
• W4296692034 hasConcept C86803240 @default.
• W4296692034 hasConceptScore W4296692034C104317684 @default.
• W4296692034 hasConceptScore W4296692034C121608353 @default.
• W4296692034 hasConceptScore W4296692034C190283241 @default.
• W4296692034 hasConceptScore W4296692034C2776202225 @default.
• W4296692034 hasConceptScore W4296692034C2778305200 @default.
• W4296692034 hasConceptScore W4296692034C2780110267 @default.
• W4296692034 hasConceptScore W4296692034C2780225316 @default.
• W4296692034 hasConceptScore W4296692034C502942594 @default.
• W4296692034 hasConceptScore W4296692034C530470458 @default.
• W4296692034 hasConceptScore W4296692034C54355233 @default.
• W4296692034 hasConceptScore W4296692034C55493867 @default.
• W4296692034 hasConceptScore W4296692034C64927066 @default.
• W4296692034 hasConceptScore W4296692034C86803240 @default.
• W4296692034 hasIssue "1" @default.
• W4296692034 hasLocation W42966920341 @default.
• W4296692034 hasLocation W42966920342 @default.
• W4296692034 hasOpenAccess W4296692034 @default.
• W4296692034 hasPrimaryLocation W42966920341 @default.

• next